Market Overview

UPDATE: Bank of America Upgrades LabCorp on 2014 Industry Clarity

Share:
Related LH
10 Companies That Saw The Biggest Jumps In The Fortune 500
A Quick-And-Easy Guide To All The Calls At Ira Sohn 2016

In a report published Friday, Bank of America Merrill Lynch analyst Robert Willoughby upgraded Laboratory Corporation of America (NYSE: LH) to Buy based on better clarity in the industry in 2014.

Willoughby noted that LabCorp of America is facing lower reimbursement and weak, continuing growth metrics. Despite these challenges and the resulting issues with earnings and growth rate, the company's recalibrated fourth quarter and 2014 EPS expectations adequately reflect these issues. In addition, “We see some potential for upside to our 2014 view of $6.50 on more accretive share repurchases. While the laboratory sub-sector remains our least favorite, clarity on industry leader Quest Diagnostics' 2014 opportunity removes an overhang on LH's stock, suggesting its shares can rebound.”

Shares of LabCorp have fallen 17.1% from a recent high in November. LapCorp closed at $89.06 on Thursday and shares are currently trading up 1.11% at $90.05.

Latest Ratings for LH

DateFirmActionFromTo
Apr 2016BarclaysMaintainsOverweight
Apr 2016UBSMaintainsNeutral
Apr 2016Canaccord GenuityMaintainsBuy

View More Analyst Ratings for LH
View the Latest Analyst Ratings

Posted-In: Bank of America Merrill Lynch Robert WilloughbyAnalyst Color Upgrades Analyst Ratings

 

Related Articles (LH)

View Comments and Join the Discussion!